Clinical trials depend on collaboration. But collaboration depends on trust. At #CVCT2026: data access, scientific independence, transparency & the future of industry-academia partnerships. Join the debate: globalcvctforum.com/scientif… #ClinicalTrials #ResearchIntegrity #CVCT

If CV prevention goes beyond ASCVD, shouldn't trial endpoints do the same? At #CVCT2026, the CVCT–@DCRINews joint session explores heart failure, AF, diabetes & how to measure prevention in at-risk populations. Are we measuring the right outcomes? globalcvctforum.com/scientif…

Can we repair the damaged heart? At #CVCT2026, experts explore cardiac regeneration, targeted biologics & emerging therapies. But should cardiology adopt accelerated pathways to bring regenerative treatments to patients? globalcvctforum.com/scientif… #CVCT #ClinicalTrials

When is a surrogate endpoint enough to demonstrate clinical benefit? At #CVCT2026, experts confront the dilemma shaping the next generation of hypertrophic cardiomyopathy trials: surrogate endpoints vs. hard clinical outcomes. globalcvctforum.com/scientif… #HCM #ClinicalTrials #CVCT

When the treatment landscape changes, clinical trials must evolve too. At #CVCT2026: cardiac amyloidosis, emerging therapies, new trial designs & the challenge of access. How do we turn innovation into meaningful patient care? globalcvctforum.com/scientif… #ATTRCM #ClinicalTrials #CVCT

A trial can show that a treatment works.But does it tell us how patients actually feel? At #CVCT2026, the CVCT–Heart Failure Collaboratory session explores how to make patient-reported outcomes meaningful in clinical trials: globalcvctforum.com/scientif… #HeartFailure #ClinicalResearch

A wearable can generate millions of data points. But when does a signal become clinical evidence? At #CVCT2026, we follow the journey from wrist→ endpoint → regulation → reimbursement → clinical practice. Join the discussion: globalcvctforum.com/scientif… #Wearables #DigitalHealth

#CVCT2026 What if the problem isn’t the therapy - but the trial designed to test it? Are standard RCT designs killing potentially effective hypertension therapies? And can cheap generic treatments coexist with innovative targeted ones? globalcvctforum.com/scientif… #Hypertension

Gene therapy could transform CV medicine. But how do you design a trial for a therapy that may be irreversible? At #CVCT2026: patient selection, durability, safety & how much evidence is enough. Is it time to rethink the trial model? globalcvctforum.com/scientif… #GeneTherapy #CVCT

#CVCT Great Debates Some questions in clinical trials don’t need another lecture. They need a debate. At #CVCT2026, experts take opposing sides on endpoints, multi-organ composites, device vs drug trials & expanded MACE. Join us Dec 7-9, Washington DC: globalcvctforum.com/scientif…

⏳ DEADLINES EXTENDED | #CVCT2026 More time to bring your research to Washington, D.C. 🔬 Late-Breaking Clinical Trials NEW deadline: October 8 📊 Poster Presentations NEW deadline: October 15 Submit: globalcvctforum.com/ #CVCT #LBCT #Posters

LAST CALL | CVCT-LMIC Fellowship Join the global clinical trials community at #CVCT2026 in Washington, DC ✈️ Travel & accommodation covered 🎓 Registration waived 🤝 Mentorship, masterclasses & networking ⏳ Apply by October 8 here: globalcvctforum.com/wac-lmic… #LMIC #ClinicalTrials

⏳ FINAL CALL for Late-Breaking Clinical Trials at #CVCT2026 Bring your latest cardiovascular, kidney & metabolic trial evidence to the global CVCT community in Washington, D.C. 🚨 Deadline: October 1 Submit your LBCT here: globalcvctforum.com/late-bre… #ClinicalTrials #LBCT #CVCT

What if one of the biggest opportunities in CV research is hiding in plain sight? At #CVCT2026, the CVCT-NHLBI joint session explores how implementation problems can become cardiovascular science - and change how care is delivered. Discover full program: globalcvctforum.com/scientif…

Who is really shaping the future of cardiovascular innovation? Academia? Industry? Regulators? CROs? Investors? At #CVCT2026, we'll discuss whether today’s cardiovascular trial model is still sustainable - and what needs to change. Join us, Dec 7-9, 2026: globalcvctforum.com/scientif…

Obesity medicine is evolving fast. Are clinical trials keeping up? At #CVCT2026 we'll discuss: • What do recent CVOTs tell us? • Is weight loss the real mechanism of benefit? • Are we seeing “the death of the pure placebo”? globalcvctforum.com/scientif… #CVCT #Obesity #GLP1

Generative AI & Autonomous Systems. Can we evaluate the unevaluable? At #CVCT2026, experts will discuss whether existing frameworks can truly assess Generative AI in clinical medicine, or whether we need to build new ones. Join us: globalcvctforum.com/scientif… #CVCT #AI

📊 Bring your research to #CVCT2026! Present your poster and discuss your work directly with investigators, regulators, industry, journals, payers & patients from across the clinical trials ecosystem. 📍 Washington, D.C. | Dec 7–9 👉 globalcvctforum.com/poster-p… #ClinicalTrials

#CVCT2026: The Think Tank we have assembled around Bayesian statistics in CV trials will discuss the foundations of Bayesian thinking, how it differs from traditional frequentist approaches, and what it brings to the interpretation of evidence. globalcvctforum.com/scientif… #CVCT

#CVCT2026: This year, CVCT examines two pivotal Phase 3 CV programs that did not meet expectations, and the critical lessons they offer for translating biological effects into improved clinical outcomes, Lp(a)HORIZON & ZEUS. Join the discussion: globalcvctforum.com/scientif… #CVCT